Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine the risk/benefit profile of a 5% minoxidil topical foam (MTF) formulation applied OD for the treatment of female pattern hair loss FPHL) in comparison to 2% minoxidil topical solution (MTS) formulation used BID, using objective efficacy measures and safety assessments.
Inclusion criteria
- FEMALE PATTERN HAIR LOSS (ANDROGENETIC ALOPECIA)